Skip to main content
. 2017 Oct 4;8(55):94028–94039. doi: 10.18632/oncotarget.21522

Figure 7. Knocking down DUSP4 reverses hypoxia-induced DOX resistance.

Figure 7

(A-D) CCK-8 assay of the viability of GC cells exposed to hypoxia alone or hypoxia + DUSP4 siRNA treated with different concentrations of DOX. (E) EDU assay of the proliferation of GC cells exposed to hypoxia alone or hypoxia + DUSP4 siRNA treated with their IC50 of DOX (***P < 0.001).